Trodelvy: An FDA-approved medication

The FDA-approved medicine Trodelvy contains Sacituzumab govitecan-hziy is used for treating patients with unresectable locally advanced or metastatic triple-negative Breast Cancer (mTNBC) and locally advanced or metastatic urothelial cancer (mUC). Trodelvy comes in single-use injection in 180 mg for intravenous use. The FDA approved this drug in 2020.
To know Trodelvy cost in India and the world or to know more, dial toll-free no. 1800-889-1064.

https://www.indianpharmanetwork.in/triple-negative-breast-cancer-and-their-treatment/ Tweet